Researchers at Queen’s University of Belfast and collaborators have developed a DNA vaccine against high-grade serous ovarian ...

Researchers from the Universitat de Barcelona and Oregon Health & Science University have developed a novel gene silencing ...

Zhejiang Jingke Pharmaceuticals Co. Ltd. has identified mast/stem cell growth factor receptor kit (KIT; c-Kit; CD117) inhibitors reported to be useful for the treatment of cancer, neurodegeneration, ...

The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to ...

Estrogen receptor-positive (ER+) breast cancer remains a major challenge even with well-defined treatment options. The ...

Naya Therapeutics Inc. is expanding its hepatocellular carcinoma pipeline with the addition of NY-700, a first-in-class ...

Sunrock Biopharma SL and Shanghai Escugen Biotechnology Co. Ltd. have joined forces in a strategic partnership to codevelop ...

After years of conversations surrounding indirect research costs, academic groups are now under the gun to quickly come up ...

Chinese researchers are preparing the details for the publication of another scientific milestone, the creation of a chimera ...

The 17 members abruptly terminated June 9 from the U.S. CDC’s Advisory Committee for Immunization Practices are not going ...

B-cell lymphoma represents about 85% of non-Hodgkin lymphoma cases; therapeutic approaches are represented by Bruton tyrosine kinase (BTK) inhibitors, but still some issues, such as drug resistance ...

Opioid use disorder (OUD) remains a significant public health crisis, with over 5 million people diagnosed in the U.S. in 2023 and more than 80,000 fatal overdoses involving opioids each year. Current ...